AI assistant
Sending…
TALPHERA, INC. — Director's Dealing 2011
Aug 31, 2011
35181_dirs_2011-08-31_14454ce7-7c2a-4f7f-aa39-35d3eea097d6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
CIK: 0001427925
Period of Report: 2011-08-29
Reporting Person: SCHRECK THOMAS A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-08-29 | Common Stock | P | 500 | $3.2682 | Acquired | 300951 | Direct |
| 2011-08-29 | Common Stock | P | 500 | $3.28 | Acquired | 17982 | Indirect |
Footnotes
F1: The shares are held in trust for Mr. Schreck's children. Mr. Schreck disclaims beneficial ownership of the shares.
More from TALPHERA, INC.
Interim / Quarterly Report
2026
May 13
Proxy Solicitation & Information Statement
2026
Apr 29
Director's Dealing
2026
Mar 26
Earnings Release
2026
Mar 23
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Feb 21
Director's Dealing
2026
Feb 21
Director's Dealing
2026
Feb 21
Director's Dealing
2026
Feb 21
Major Shareholding Notification
2026
Feb 17